This epigenetics delves into the influence of epigenetic changes—such as DNA methylation, histone modifications, and non-coding RNAs—on skin diseases including psoriasis, vitiligo, and melanoma. Experts will examine how these reversible changes can serve as biomarkers or therapeutic targets, offering insights into precision medicine for dermatologic care.